The Rest Of Asia Pacific Long Read Sequencing Market was valued at $23 Million in 2024 and projected to reach to $104.3 Million by 2029, representing a compound annual growth rate of 35.3%. Rest Of Asia Pacific represents one of the most dynamic segments in the global long read sequencing market, with exceptional growth momentum driven by healthcare infrastructure development and increased genomic research funding.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
Rest Of Asia Pacific's long read sequencing market is growing at 35.3% CAGR, outpacing the global average of 32.8%, driven by increasing genomic research initiatives and healthcare modernization across emerging economies in the region.
Market valuation is projected to surge from $23.0 million in 2024 to $104.3 million by 2029, representing a 353% increase over five years, reflecting strong regional demand for advanced sequencing technologies.
Growing demand for precision medicine applications in Rest Of Asia Pacific is accelerating long read sequencing adoption, with healthcare providers increasingly investing in genomic diagnostics for personalized treatment strategies.
Rising healthcare expenditures and government support for genomic research infrastructure across Rest Of Asia Pacific countries are creating favorable conditions for long read sequencing market penetration and technology deployment.
| Report Metric | Details |
|---|---|
| Base Year | 2024 |
| Fastest Growing Segment | DATA ANALYSIS (Workflow) |
| Forecast Period | 2024-2029 |
| Growth Rate | CAGR of 32.8% from 2024 to 2029 |
| Largest Segment | RESEARCH USAGE (Usage) |
| Market Size Base Year (Billions) | ~USD 0.76 (2024) |
| Revenue Forecast (Billions) | ~USD 3.13 (2029) |
| Segments Covered | Offering, Technology, Workflow, Application, Usage, End User |
6 segment dimensions are covered across the global market.
Rest Of Asia Pacific long read sequencing market was valued at $23.0 million in 2024 and is projected to grow to $104.3 million by 2029.
Rest Of Asia Pacific is experiencing a compound annual growth rate of 35.3% from 2024 to 2029, significantly outpacing global market growth.
Rest Of Asia Pacific growth is driven by increasing healthcare investments, rising adoption of genomic technologies, government funding for research, and expanding precision medicine applications.
Rest Of Asia Pacific includes emerging economies establishing genomic research centers and clinical sequencing capabilities, with growth concentrated in countries with strong healthcare infrastructure investments.
Rest Of Asia Pacific's 35.3% CAGR exceeds the global average of 32.8%, positioning the region as one of the fastest-growing markets for long read sequencing technology.
This study on the long-read sequencing market employed secondary sources, directories, and databases to gather pertinent information. To gather and validate important qualitative and quantitative data and evaluate market growth prospects, in-depth interviews were conducted with many primary respondents including key industry participants, subject-matter experts (SMEs), C-level executives from key market players, and industry consultants. After estimating the long-read sequencing market using several research strategies, the size of the final market was obtained by triangulating data from primary research.
The secondary sources referred to for this research study include publications from government sources. These include Nucleic Acids Research, Genome Biology, Nature Reviews Genetics, Nature Methods, Genome Research, International Journal of Genomics, National Human Genome Research Institute (NHGRI), International Chromosome and Genome Society (ICGS), Genome Canada, European Society of Human Genetics (ESHG), Genomics England, Genome British Columbia, Beijing Institute of Genomics, Centre for Cellular & Molecular Biology (CCMB), São Paulo Research Foundation (FAPESP), National Cancer Institute (NCI), European Medicines Agency (EMA), Biotechnology and Biological Sciences Research Council (BBSRC), Organisation for Economic Co-operation and Development (OECD), Population Health Research Institute (PHRI), PubMed, World Bank, and the World Health Organization (WHO), among others. Secondary sources also included corporate & regulatory filings, such as annual reports, SEC filings, investor presentations, and financial statements; business magazines & research journals; press releases; and trade, business, and professional associations. Secondary data was collected and analyzed to arrive at the overall size of the global long-read sequencing market, which was validated through primary research.
Extensive primary research was conducted after acquiring basic knowledge about the global long-read sequencing market scenario through secondary research. Several primary interviews were conducted with market experts from the supply side, such as C-level and D-level executives, operational managers, marketing & sales managers of key manufacturers, distributors, and channel partners of companies providing long-read sequencing; experts from the demand side, such as personnel from academic & research institutes, hospitals, clinics and diagnostic labs, pharmaceutical & biopharmaceutical industries. These interviews were conducted across six major regions, including North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa. Approximately 70% and 30% of the primary interviews were conducted with supply-side and demand-side participants, respectively. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.
The following is a breakdown of the primary respondents:

To know about the assumptions considered for the study, download the pdf brochure
Both top-down and bottom-up approaches were used to estimate and validate the total size of the long-read sequencing market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

To know about the assumptions considered for the study, Request for Free Sample Report
After arriving at the overall market size from the market size estimation process, the total market was split into several segments and subsegments.

To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Long-read sequencing is a type of nucleic acid sequencing that produces genomic data by generating individual reads from single molecules, generally ranging in size from 700 to over 20,000 bases. These fragments are typically derived from "native" molecules, which are directly extracted from biological samples for analysis. The long-read sequencing market encompasses the consumables, instruments, services, and technology associated with long-read sequencing. The long-read sequencing market is defined as solutions including instruments/systems, consumables (kits, reagents, flow cells), and services for long-read sample preparation, sequencing, and data analysis. Long-read software solutions are often provided alongside the instrument/system/platform, hence the software solutions are considered within the instrument segment scope. Other standalone software solutions are provided as data analysis services and are considered within the services segment scope.
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:
Full forecast, segment splits, and company analysis for all Long Read Sequencing Market.
Customize this report to your needs
Get 10% FREE Customization
Customize This Report